Denmark· DK-28104707810

Danilon Equidos

A qm01aa90 product containing suxibuzon, registered in Denmark by Ecuphar Veterinaria S.L.U..

ATC QM01AA90

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedDanilon EquidosATCQM01AA90REGISTER NO.DK-28104707810PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Suxibuzon
Manufacturer
Ecuphar Veterinaria S.L.U.
Country
Denmark (DK)
ATC code
QM01AA90
ATC class
QM01AA90
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104707810

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QM01AA90

Qm01aa90, as other registers publish it.

All suxibuzon products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e57a79a2-7415-4f7a-a79f-0a023842c243
GET /v1/drugs/e57a79a2-7415-4f7a-a79f-0a023842c243?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "granulat",
  "source": "dkma",
  "strength": "1,5 g",
  "auth_role": "CMS",
  "dk_drugid": "28104707810",
  "substance": "Suxibuzon",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "40737"
}

See everything about suxibuzon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.